Schöffski, P.; Gebreyohannes, Y.; Van Looy, T.; Manley, P.; Growney, J.D.; Squires, M.; Wozniak, A.
In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor. Biomedicines 2022, 10, 1135.
https://doi.org/10.3390/biomedicines10051135
AMA Style
Schöffski P, Gebreyohannes Y, Van Looy T, Manley P, Growney JD, Squires M, Wozniak A.
In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor. Biomedicines. 2022; 10(5):1135.
https://doi.org/10.3390/biomedicines10051135
Chicago/Turabian Style
Schöffski, Patrick, Yemarshet Gebreyohannes, Thomas Van Looy, Paul Manley, Joseph D. Growney, Matthew Squires, and Agnieszka Wozniak.
2022. "In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor" Biomedicines 10, no. 5: 1135.
https://doi.org/10.3390/biomedicines10051135
APA Style
Schöffski, P., Gebreyohannes, Y., Van Looy, T., Manley, P., Growney, J. D., Squires, M., & Wozniak, A.
(2022). In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor. Biomedicines, 10(5), 1135.
https://doi.org/10.3390/biomedicines10051135